| Literature DB >> 32451673 |
Timo C Meine1, Cornelia L A Dewald1, L S Becker1, Aline Mähringer-Kunz2, Benjamin Massoumy3, Sabine K Maschke1, Martha M Kirstein3, Thomas Werncke1, Frank K Wacker1, Bernhard C Meyer1, Jan B Hinrichs4,5.
Abstract
BACKGROUND: To assess the technical feasibility, success rate, puncture complications and procedural characteristics of transjugular intrahepatic portosystemic shunt (TIPS) placement using a three-dimensional vascular map (3D-VM) overlay based on image registration of pre-procedural contrast-enhanced (CE) multi-detector computed tomography (MDCT) for portal vein puncture guidance.Entities:
Keywords: Image registration; Image-guided therapy; Operator experience; Transjugular intrahepatic portosystemic shunt; Venous intervention
Mesh:
Year: 2020 PMID: 32451673 PMCID: PMC7593285 DOI: 10.1007/s00261-020-02589-1
Source DB: PubMed Journal: Abdom Radiol (NY)
Fig. 13D/2D image registered 3D-VM. In A the direct portography with the TIPS sheath in the main portal trunk after successful portal vein puncture is shown. In B the 3D-VM is illustrated with the right hepatic vein indicated in blue, the main portal trunk and the right portal vein in green and the left portal vein in red. Vertebral bodies and rips were superimposed to confirm the alignment during the procedure. Note: Both images are displayed in the angio suite during the intervention in real-time. Abbreviations: 2D = two-dimensional, 3D = three-dimensional, 3D-VM = three-dimensional vascular map
Patient’s characteristics
| Patient’s Characteristics | |
|---|---|
| Age (years) | 59 ± 9 |
| Sex (male/female) | 18/9 |
| BMI (kg/m2) | 24 ± 6 |
| MELD score | 11 ± 5 |
| Liver disease | |
| Ethyltoxic | 11 |
| HBV | 1 |
| HCV | 2 |
| NASH | 3 |
| BC | 3 |
| HC | 1 |
| Post-LTx | 2 |
| Cryptogenic | 4 |
| Indication | |
| Refractory variceal or gastrointestinal bleeding | 6 |
| Refractory ascites and hydrothorax | 21 |
| Clinical significant complication | |
| Subcapsular hematoma | 0 |
| Intraperitoneal hemorrhage | 0 |
| Death | 0 |
| Additional procedures | |
| Second stent placement | 2 |
| Variceal embolization | 8 |
| Technical success | |
| Success rate | 27/27 |
| Preprocedural PSG (mmHg) | 15 ± 3 |
| Postprocedural PSG (mmHg) | 4 ± 3 |
Sex, age, body-mass-index (BMI), model of endstaged liver disease (MELD) score, liver disease, indication, clinical significant complication, additional procedures and technical success were tabulated
BC Budd-Chiari syndrome, HBV hepatitis virus B, HC hemochromatosis, HCC hepatocellular carcinoma, HCV hepatitis virus C, NASH non-alcoholic steatohepatitis, post-LTx cirrhosis after orthotopic liver transplantation, PSG portosystemic gradient
Procedural characteristics and comparison to literature
| Procedural characteristics | Study group | Böning et al. | Ketelsen et al. | Luo et al.‘18 | Luo et al.‘17 | Rouabah et al. |
|---|---|---|---|---|---|---|
| Planning modality | CE-MDCT | CE-MDCT or CE-CACT | CE-CACT | CE-CACT | CE-MDCT | MDCTA |
| Vascular label | hv, pvb | pvb, vnp | pvb | pvb | hv, pvb | pvb |
| Image registration technique | CE-MDCT on FS | CE-MDCT/CACT on FS or CE-CACT on FS | CE-CACT on FS | CE-CACT on FS | CE-MDCT/CACT on FS | MDCTA on FS |
| 3D/2D | 3D/3D or 3D | 3D | 3D | 3D/3D | 3D/2D | |
| Number of patients | 27 | 21 | 12 | 20 | 15 | 18 |
| Hepatic vein catherization time (min) | 14 ± 11 | n.a. | n.a. | n.a. | n.a. | n.a. |
| Puncture time (min) | 14 ± 6 | 32 ± 45 | 14 ± 8 | n.a. | n.a. | 17 ± 9 |
| Overall procedure time (min) | 64 ± 29 | 115 ± 52 | 66 ± 29 | n.a. | 60 ± 13 | n.a. |
| Fluoroscopy time (min) | 21 ± 12 | n.a. | 18 ± 9 | 11 ± 2 | 14 ± 4 | n.a. |
| Number of DSA series | 4, 3–6 | n.a. | 17.5, 15.25–23.5 | n.a. | n.a. | n.a. |
| Dose area product (Gy cm2) | 107.48 ± 93.84 | 563.00 ± 289.00 | 188.16 ± 121.18 | 295.50 ± 66.60 | 152.11 ± 86.63 | 258.53 ± 161.41 |
Image registration technique, number of patients, overall procedure time, fluoroscopy time, number of DSA series and Dose-Area-Product were tabulated for the study population and the literature. Times were shown as median ± standard deviation. Number of Digital Substraction Angiography (DSA) series were tabulated as median and range (minimum-maximum)
2D two-dimensional, 3D three-dimensional, CE contrast enhanced, CACT C-arm-computed tomography, MDCT multi-detector-computed tomography, MDCTA contrast-enhanced multi-detector-computed tomographic angiography, n.a. not available, FS fluoroscopy, hv hepatic veins, pvb portal vein branches, vnp virtual needle path (from the catheter in the hepatic vein to the portal vein branch). Data of the publication by Tacher et al. and Chivot et al. are mentioned in the text, because they reported median and range
Comparison of patient’s and procedural characteristics between interventionalists with limited experience
| Patient’s Characteristics | 3D/2D | CFS | |
|---|---|---|---|
| Age (years) | 61 ± 9 | 53 ± 9 | 0.0030 |
| Sex (male/female) | 14/8 | 21/9 | 0.7665 |
| BMI (kg/m2) | 25 ± 7 | 25 ± 5 | 0.5651 |
| MELD score | 11 ± 4 | 11 ± 6 | 0.8892 |
| Liver disease (ethyltoxic/non-ethyltoxic) | 9/13 | 13/17 | 1 |
| Indication (ref. bleeding/ref. ascites and hydrothorax) | 4/18 | 7/23 | 0.7411 |
| Clinical significant complication | 0 | 0 | 1 |
| Additional procedures | |||
| Second stent placement | 0 | 2 | 0.4996 |
| Variceal embolization | 7 | 3 | 0.0789 |
| Technical success | |||
| Success rate | 22 | 29 | 1 |
| Preprocedural PSG (mmHg) | 16 ± 4 | 15 ± 5 | 0.2887 |
| Postprocedural PSG (mmHg) | 4 ± 3 | 6 ± 3 | 0.0356 |
| Procedural characteristics | 3D/2D | CFS | |
| Hepatic vein catheterization time (min) | 12 ± 7 | 28 ± 18 | 0.0022 |
| Puncture time (min) | 13 ± 6 | 19 ± 15 | 0.2905 |
| Overall procedure time (min) | 53 ± 13 | 85 ± 27 | 0.0097 |
| Fluoroscopy time (min) | 16 ± 7 | 27 ± 12 | 0.0009 |
Patient’s and procedural characteristics for the study populations of the interventionalists with limited experience using 3D/2D image registered 3D-VM (3D/2D) and classical fluoroscopic guidance (CFS) were compared. Patient’s characteristics included sex, age, body-mass-index (BMI), model of endstaged liver disease (MELD) score, liver disease, indication, clinical significant complication, additional procedures and technical success were tabulated. Procedural characteristics were hepatic vein catherization time, overall procedure time and fluoroscopy time. Values for TIPS placement with classical fluoroscopic guidance were obtained from a previous cohort of our publication by Marquardt et al. [11]. Continuous variables were shown as mean ± standard deviation. p values were reported for two-sided Mann–Whitney-U test for continuous variables or two-sided Fischer’s exact test for category variables between interventionalists with limited experience performing TIPS placements with 3D/2D image registered 3D-VM and classical fluoroscopic guidance
2D two-dimensional, 3D three-dimensional, 3D-VM three-dimensional vascular map, PSG portosystemic gradient, ref. bleeding refractory variceal or gastrointestinal bleeding, ref. ascites and hydrothorax refractory ascites and hydrothorax